[{"NetIncomeLoss_1_Q3_USD":68218000.0,"Liabilities_0_Q3_USD":220555000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":58000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":8.34,"GeneralAndAdministrativeExpense_3_Q3_USD":48755000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":19563000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InterestPaidNet_3_Q3_USD":1836000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":11000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":19879702000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":50902000.0,"PaymentsToAcquireInvestments_3_Q3_USD":66342000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2825431.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":8000.0,"AssetsCurrent_0_Q3_USD":358811000.0,"LongTermDebt_0_Q3_USD":25000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":10.08,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":17.89,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":12.11,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":11970000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":739988000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":11588000.0,"Assets_0_Q3_USD":396293000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":125715000.0,"CommonStockSharesIssued_0_Q3_shares":91841974.0,"DueToRelatedPartiesCurrent_0_Q3_USD":26734000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":174000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":7075000.0,"ShareBasedCompensation_3_Q3_USD":14548000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":5789000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":125982000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":227460000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":105139000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":39882000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":11.28,"EarningsPerShareBasic_3_Q3_USD":-0.17,"EarningsPerShareBasic_1_Q3_USD":0.74,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":91649035.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":94953117.0,"RestrictedInvestmentsNoncurrent_0_Q3_USD":2150000.0,"ProceedsFromStockPlans_3_Q3_USD":827000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-729000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-35000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1250000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q3_USD":-1000.0,"CommonStockValue_0_Q3_USD":92000.0,"Revenues_3_Q3_USD":137706000.0,"OtherAssetsNoncurrent_0_Q3_USD":601000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":4781000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":68217000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-15519000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":68218000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-15577000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":12231000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":119915000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":1493000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":4395000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":5788000.0,"LongTermNotesPayable_0_Q3_USD":16117000.0,"Revenues_1_Q3_USD":126725000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1958000.0,"ShortTermInvestments_0_Q3_USD":119927000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":136636000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":58000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":949000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":19000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5846000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":58551000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":91649035.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":91757614.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":119927000.0,"LiabilitiesCurrent_0_Q3_USD":94591000.0,"AccountsPayableCurrent_0_Q3_USD":8623000.0,"NonoperatingIncomeExpense_3_Q3_USD":-516000.0,"NonoperatingIncomeExpense_1_Q3_USD":-189000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":227460000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":10174000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1131000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1630000.0,"NetIncomeLoss_3_Q3_USD":-15577000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":17355000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":10950342000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3_Q3_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":316000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":38716000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":435000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":281668.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":68218000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-15577000.0,"InterestExpenseDebt_1_Q3_USD":744000.0,"InterestExpenseDebt_3_Q3_USD":2172000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":12081000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"EarningsPerShareDiluted_1_Q3_USD":0.72,"CommonStockSharesOutstanding_0_Q3_shares":91841974.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":126725000.0,"OperatingIncomeLoss_3_Q3_USD":-15061000.0,"OperatingIncomeLoss_1_Q3_USD":68407000.0,"NotesPayableCurrent_0_Q3_USD":9345000.0,"InvestmentIncomeInterest_3_Q3_USD":2385000.0,"InvestmentIncomeInterest_1_Q3_USD":590000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":22.27,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.89,"LiabilitiesAndStockholdersEquity_0_Q3_USD":396293000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":7006000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":14548000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5846000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":1677450.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":56071000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":6099000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-8137000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":111411000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-564353000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5197692.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":10903443.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-2097000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.17,"LongTermInvestments_0_Q3_USD":5788000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":7988000.0,"StockholdersEquity_0_Q3_USD":175738000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":8203000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":4839000.0,"OperatingExpenses_1_Q3_USD":58318000.0,"OperatingExpenses_3_Q3_USD":152767000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":125704000.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]